Upconversion nanoparticles regulated drug & gas dual-effective nanoplatform for the targeting cooperated therapy of thrombus and anticoagulation

Thromboembolism is the leading cause of cardiovascular mortality. Currently, for the lack of targeting, short half-life, low bioavailability and high bleeding risk of the classical thrombolytic drugs, pharmacological thrombolysis is usually a slow process based on micro-pumping. In addition, frequen...

Descripción completa

Detalles Bibliográficos

Autores principales:	Shichen Liu, Yao Sun, Teng Zhang, Longtao Cao, Zhiwei Zhong, Haoxin Cheng, Qingqing Wang, Zhuang Qiu, Weimin Zhou, Xiaolei Wang
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	KeAi Communications Co., Ltd. 2022-12-01
Colección:	Bioactive Materials
Materias:	Targeted drug delivery Upconversion nanoparticles Controlled release Thrombus Anticoagulation
Acceso en línea:	http://www.sciencedirect.com/science/article/pii/S2452199X22001293
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!